Haoxi Health Technology Limited Announces Preliminary Unaudited Financial Results for Fiscal Year 2024
BEIJING, Oct. 07, 2024 — Haoxi Health Technology Limited (“HAO” or “the Company”), a leading online marketing solution provider based in Beijing, China, has released its preliminary unaudited financial results for the fiscal year ending June 30, 2024 (“FY24”). The Company projects significant revenue growth for FY24, attributing this success to its strategic development in online advertising solutions, particularly through short video formats and news feed ads.
The Company’s proprietary data analysis software, Bidding Compass, has played a crucial role in optimizing ad placements, which HAO believes has driven growth in both revenue and profit for FY24. Key financial highlights include:
- Revenue: Approximately $48.52 million for FY24, representing a 72% increase compared to $28.23 million in FY23.
- Gross Profit: Approximately $2.75 million for FY24, a 33.4% increase from $2.06 million in FY23.
- Net Income: Approximately $1.29 million for FY24, reflecting a 33.2% increase from $0.97 million in FY23.
- Total Assets: As of June 30, 2024, the Company’s total assets increased to approximately $15.51 million, up from $4.46 million at the end of FY23.
Since its initial public offering (IPO) in January 2024, HAO has experienced consistent growth in its core business, benefiting from the demand for targeted healthcare advertising in China. The Company’s strong relationships with major media platforms, combined with its expertise in planning, placing, and optimizing short video ads, has reinforced its goal to become a leading player in the digital healthcare advertising market.
“We believe that our preliminary FY24 results reflect the strength of our business model and our team’s ability to navigate through a rapidly evolving online advertising landscape,” said Mr. Zhen Fan, CEO of Haoxi Health Technology Limited. “Our dedicated team, coupled with our focus on the healthcare sector, has enabled us to consistently deliver value to our clients. We look forward to maintaining this momentum as we continue to expand our partnerships and enhance our service offerings.”
As the healthcare sector continues to expand in China, HAO remains committed to capitalizing on these opportunities. With its experience in ad placement strategies and established partnerships with online advertising platforms in China, the Company aims to further strengthen its foothold in the market.
Note About Preliminary Results
The financial results presented in this release are preliminary and may change. This preliminary financial information includes calculations or figures prepared internally by management. The Company’s independent registered public accounting firm has not completed its audit of, and does not express an opinion on, these data. There can be no assurance that the Company’s actual results for the period presented will not differ from the preliminary financial results, and such changes could be material.
About Haoxi Health Technology Limited
Haoxi Health Technology Limited is a Beijing-based online marketing solution provider in China, specializing in serving healthcare industry advertisers. The Company’s growth is driven by the rise of news feed ads and the rapid development of the healthcare sector. HAO offers one-stop online marketing solutions, particularly in online short video marketing, helping advertisers acquire and retain customers on popular platforms in China.
For more information, please visit: http://ir.haoximedia.com.
Forward-Looking Statement
This press release contains forward-looking statements that involve risks and uncertainties. These statements are subject to uncertainties and risks, including market conditions and other factors particular to our industry. Investors are cautioned not to place undue reliance on these forward-looking statements. For more information, please contact: Investor Relations WFS Investor Relations Inc. Janice Wang, Managing Partner Email: services@wealthfsllc.com Phone: +86 13811768599 / +1 628 283 9214
